Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

@article{Kirn2009TargetedAA,
  title={Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer},
  author={David H. Kirn and Steve Thorne},
  journal={Nature Reviews Cancer},
  year={2009},
  volume={9},
  pages={64-71}
}
Viruses have been engineered for cancer therapy in a variety of ways. Approaches include non-replicating gene therapy vectors, cancer vaccines and oncolytic viruses, but the clinical efficacy of these approaches has been limited by multiple factors. However, a new therapeutic class of oncolytic poxviruses has recently been developed that combines targeted and armed approaches for treating cancer. Initial preclinical and clinical results show that products from this therapeutic class can… CONTINUE READING
BETA

Similar Papers

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 197 CITATIONS, ESTIMATED 46% COVERAGE

The mechanisms of genetically modified vaccinia viruses for the treatment of cancer.

  • Critical reviews in oncology/hematology
  • 2015
VIEW 8 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Virotherapy, gene transfer and immunostimulatory monoclonal antibodies

VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Progress in gene therapy using oncolytic vaccinia virus as vectors

  • Journal of Cancer Research and Clinical Oncology
  • 2018
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2009
2019

CITATION STATISTICS

  • 15 Highly Influenced Citations

  • Averaged 12 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 150 REFERENCES

New developments in multitargeted therapy for patients with solid tumours

C. Le Tourneau, S. Faivre, E. Raymond
  • Cancer Treat. Rev. 34,
  • 2008

Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma

Gulley, L J.
  • Clin. Cancer Res
  • 2008

Reovirus: viral therapy for cancer 'as nature intended'.

  • Clinical oncology (Royal College of Radiologists (Great Britain))
  • 2008